EE90 Budget Impact Analysis of Introducing the Elecsys® PRO-C3 Assay as Part of the ADAPT Algorithm for Assessing the Severity of Hepatic Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the UK
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.474
https://www.valueinhealthjournal.com/article/S1098-3015(25)03031-1/fulltext
Title :
EE90 Budget Impact Analysis of Introducing the Elecsys® PRO-C3 Assay as Part of the ADAPT Algorithm for Assessing the Severity of Hepatic Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03031-1&doi=10.1016/j.jval.2025.09.474
First page :
Section Title :
Open access? :
No
Section Order :
10079